Genetic evidence for cytochrome b Qi site inhibition by 4(1H)-quinolone-3-diarylethers and antimycin in Toxoplasma gondii

P. Holland Alday, Igor Bruzual, Aaron Nilsen, Sovitj Pou, Rolf Winter, Choukri Ben Mamoun, Michael Riscoe, Joseph Doggett

Research output: Contribution to journalArticle

22 Scopus citations

Abstract

Toxoplasma gondii is an apicomplexan parasite that causes fatal and debilitating brain and eye disease. Endochinlike quinolones (ELQs) are preclinical compounds that are efficacious against apicomplexan-caused diseases, including toxoplasmosis, malaria, and babesiosis. Of the ELQs, ELQ-316 has demonstrated the greatest efficacy against acute and chronic experimental toxoplasmosis. Although genetic analyses in other organisms have highlighted the importance of the cytochrome bc1 complex Qi site for ELQ sensitivity, the mechanism of action of ELQs against T. gondii and the specific mechanism of ELQ-316 remain unknown. Here, we describe the selection and genetic characterization of T. gondii clones resistant to ELQ-316. A T. gondii strain selected under ELQ-316 drug pressure was found to possess a Thr222-Pro amino acid substitution that confers 49-fold resistance to ELQ-316 and 19-fold resistance to antimycin, a well-characterized Qi site inhibitor. These findings provide further evidence for ELQ Qi site inhibition in T. gondii and greater insight into the interactions of Qi site inhibitors with the apicomplexan cytochrome bc1 complex.

Original languageEnglish (US)
Article numbere01866
JournalAntimicrobial Agents and Chemotherapy
Volume61
Issue number2
DOIs
StatePublished - Feb 1 2017

Keywords

  • Apicomplexan parasites
  • Cytochrome b
  • Cytochrome bc
  • Drug targets
  • Experimental therapeutics
  • Mechanisms of action
  • Mitochondria
  • Parasitology
  • Preclinical drug studies
  • Toxoplasma gondii

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Genetic evidence for cytochrome b Q<sub>i</sub> site inhibition by 4(1H)-quinolone-3-diarylethers and antimycin in Toxoplasma gondii'. Together they form a unique fingerprint.

  • Cite this